Literature DB >> 3724144

The endogenous concentration of estradiol and estrone in pathological human postmenopausal endometrium.

C Vermeulen-Meiners, J Poortman, A A Haspels, J H Thijssen.   

Abstract

The endogenous estrone (E1) and estradiol (E2) levels (in pg/g tissue) were measured in 7 postmenopausal patients with a hyperplastic endometrium, in 3 with an atypical adenomatous hyperplastic endometrium and in 13 with a carcinomatous endometrium. These tissue concentrations were compared with the E1 and E2 concentrations in plasma (pg/ml) and with data from a control group of postmenopausal women with atrophic endometria. The tissue levels of both steroids showed large variations and there were no significant correlations with their plasma levels. In the hyperplastic and the atypical adenomatous hyperplastic group the mean E2 tissue level was higher compared with the mean E1 tissue level, despite the excess of E1 over E2 in peripheral plasma. In the carcinomatous group the mean E1 tissue level was higher, although not significantly, than the mean E2 tissue level. There were no significant differences between the E1 and E2 tissue levels in the three different pathological groups as compared to the atrophic control group. We conclude that it is unlikely that estrogens alone play a crucial role in the development of a pathological endometrium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3724144     DOI: 10.1016/0022-4731(86)90362-6

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  4 in total

1.  The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.

Authors:  Paul A Foster; L W Lawrence Woo; Barry V L Potter; Michael J Reed; Atul Purohit
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

2.  Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.

Authors:  Taija Saloniemi; Päivi Järvensivu; Pasi Koskimies; Heli Jokela; Tarja Lamminen; Sadaf Ghaem-Maghami; Roberto Dina; Pauliina Damdimopoulou; Sari Mäkelä; Antti Perheentupa; Harry Kujari; Jan Brosens; Matti Poutanen
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

3.  Aromatase excess in cancers of breast, endometrium and ovary.

Authors:  Serdar E Bulun; Dong Chen; Meiling Lu; Hong Zhao; Youhong Cheng; Masashi Demura; Bertan Yilmaz; Regina Martin; Hiroki Utsunomiya; Steven Thung; Emily Su; Erica Marsh; Amy Hakim; Ping Yin; Hiroshi Ishikawa; Sanober Amin; Gonca Imir; Bilgin Gurates; Erkut Attar; Scott Reierstad; Joy Innes; Zhihong Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

4.  Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer.

Authors:  L M Berstein; A E Tchernobrovkina; V B Gamajunova; A J Kovalevskij; D A Vasilyev; O F Chepik; E A Turkevitch; E V Tsyrlina; S J Maximov; L A Ashrafian; J H H Thijssen
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-15       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.